Navigation Links
Postcode inequality for cancer diagnosis 'costs lives'

Hundreds of women with breast cancer living in England's most deprived areas would have better survival rates if they were diagnosed at the same stage as those who lived in affluent areas.

A new study led by the University of Leicester, working with colleagues from Public Health England and the University of Cambridge, investigated how much of a difference late-stage diagnosis had on women from deprived areas.

The team calculated how many deaths would be postponed beyond 5 years from diagnosis if as many women in the more deprived areas were diagnosed at an earlier stage as those in most affluent areas.

The researchers were funded by both Cancer Research UK and The National Institute for Health Research (NIHR). Their work will be published in the International Journal of Cancer and is available on line ahead of publication at

The research team consisted of:

At the University of Leicester, Department of Health Sciences: Dr Mark Rutherford, Sally Hinchliffe and Professor Paul Lambert.

At the University of Cambridge, Centre for Health Services Research, Institute of Public Health: Dr Gary Abel, Dr Georgios Lyratzopoulos and Dr David Greenberg.

Dr Mark Rutherford, of the Department of Health Sciences at the University of Leicester, said: "A number of previous studies have shown poorer breast cancer survival for women who live in more deprived areas. Our study looks at how much of these differences are due to later stage disease at diagnosis for women who live in more deprived areas.

"We found that for a typical yearly cohort of breast cancer patients in England, 450 deaths could have been postponed beyond 5 years of diagnosis if the stage distribution for all women matched that of the most affluent."

The teams from the University of Leicester and University of Cambridge used data from the Eastern Cancer Registry who have good information on stage at diagnosis, but made some assumptions when estimating figures for the whole of England.

Dr Rutherford added: "Our research highlights that important and significant improvements could be made in terms of the number of early deaths that are observed for women living in more deprived areas by concentrating on making sure these women are diagnosed earlier.

"The findings suggest that policies aimed at reducing inequalities in stage at diagnosis between women with breast cancer are important to reduce inequalities in breast cancer survival.

"Being diagnosed with earlier stage disease has a significant impact on survival chances. It is clear from the results of the study that women from more deprived areas are more likely to be diagnosed with advanced stage disease. Removing these deprivation inequalities in stage at diagnosis can substantially reduce the number of deaths in the short-term for more deprived women."

Dr Martine Bomb, head of early diagnosis at Cancer Research UK, said: "There is already good evidence that breast cancer survival is poorer among more deprived women, and this research helps us understand more about why that might be. More needs to be done to tackle this inequality to ensure everyone has the same chance of surviving breast cancer, no matter where they live.

"Cancer Research UK is working in partnership with others to help people get to know their bodies, know what signs to look out for that could be cancer and see their doctor sooner rather than later if they have noticed something out of the ordinary. Spotting breast cancer at an early stage makes a real difference to women's chance of surviving the disease, and we must ensure this is a reality for all."


Contact: Mark Rutherford
University of Leicester

Related medicine news :

1. Wellesley study shows income inequality a key factor in high US teen births
2. Conference brings global focus to social inequality
3. Heart disease map of England highlights growing social inequality in older ages
4. Schizophrenia linked to social inequality
5. Study Suggests Vaccine May Help Kids With Brain Cancer
6. New Stool Test Might Aid in Early Detection of Colon Cancer
7. Study reveals how cancer drug causes diabetic-like state
8. How a cancer drug leads to diabetes
9. You Survived Cancer: Now Pay Attention to Your Overall Health
10. New drug prevents spread of human prostate cancer cells
11. Eliminating the good cholesterol receptor may fight breast cancer
Post Your Comments:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: